Best peptides for libido and sexual function.

A small category containing a genuinely approved drug and a widely-sold unapproved compound trading on its mechanism.

Ranked by published evidence · reviewed June 1, 2026

Sexual function peptides are unusual in that the category's headline compound actually cleared the FDA. Bremelanotide, sold as Vyleesi, is approved for hypoactive sexual desire disorder in premenopausal women. Importantly, it works through the melanocortin system in the brain rather than through the vascular mechanism most people associate with sexual function drugs, which means it acts on desire rather than on blood flow.

That approval is regularly borrowed by adjacent compounds. Melanotan II shares the melanocortin mechanism, is widely sold, and is not approved anywhere. Its reputation rests on sharing a receptor family with an approved drug, which is a reason to investigate a compound and not evidence that it is safe or effective. It also carries the photosensitivity and pigmentation effects that come with melanocortin activity.

The other approved compounds in this list work through the reproductive hormone axis rather than on desire directly. Gonadorelin is synthetic GnRH, the hypothalamic signal that starts the entire reproductive cascade, and HCG mimics luteinizing hormone. Both have decades of documented clinical use for fertility and specific endocrine indications. Their popular use alongside testosterone therapy to preserve testicular function is common in practice and considerably less well studied than their approved indications.

One pharmacological detail here is genuinely counterintuitive. GnRH signalling depends on the pattern of delivery rather than just the amount: pulsed intermittent exposure stimulates the axis, while continuous exposure desensitizes the receptor and shuts it down. This is why the same molecular target is used both to restore fertility and, with long-acting agonists, to suppress hormone production entirely in prostate cancer treatment.

The honest verdict

One approved drug with real trial evidence, an unapproved analog trading on the same mechanism, and a set of fertility-axis hormones whose approved uses are well evidenced while their popular off-label uses are not.

Ranked by evidence.

Ordered by PepCue's evidence tier, not by claimed effect size. A compound with a larger reported result but less human data ranks below one that has actually been tested.

FAQ.

Is PT-141 approved?

Yes. Bremelanotide is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. That approval is specific and does not extend to general libido enhancement in other populations.

How is Melanotan II different?

It shares the melanocortin mechanism but is not approved anywhere, is sold as an unregulated research chemical, and carries pigmentation and photosensitivity effects. Sharing a mechanism with an approved drug is not equivalent to sharing its evidence.